This department is offering a grant to continue support for the AIDS Malignancy Consortium (AMC) to conduct clinical interventions, develop effective therapeutics, study the biology of HIV malignancies, manage international issues, and distribute tumor tissue. The grant requires AMC to have a Coordination Center, Clinical Trial Sites, Network Laboratories, and a Statistical Center, with scientific Working Groups focusing on specific cancer types. The Network Laboratories will support clinical trials, correlative studies, and pharmacology studies. All clinical trials must be open to participants of all racial/ethnic groups. Closing date for applications is January 10, 2020.
Opportunity ID: 320521
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-19-056 |
| Funding Opportunity Title: | Limited Competition: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trials Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 11, 2019 |
| Last Updated Date: | Sep 11, 2019 |
| Original Closing Date for Applications: | Jan 10, 2020 |
| Current Closing Date for Applications: | Jan 10, 2020 |
| Archive Date: | Feb 15, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See the funding announcements for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the proposed Funding Opportunity Announcement (FOA) is to continue support for AIDS Malignancy Consortium (AMC). AMC is a major infrastructure intended to stimulate cooperative research efforts in the following areas: 1) Design, development, and evaluation of clinical interventions for the prevention and treatment of HIV-associated malignancies; Development of more effective therapeutics and management strategies for HIV-associated malignancies; Investigation of the biology of HIV malignancies within the context of clinical trials; Management of issues of international importance in HIV associated-malignancies; and Distribution of excess tumor tissue and other relevant biologic fluids to the AIDS and Cancer Specimen Resource for ongoing or future investigations. The AMC must consist of the following functional units: a Coordination Center, Clinical Trial Sites, Network Laboratories, and a Statistical Center. The AMC team must have at least four scientific disease-oriented Working Groups to study Kaposi Sarcoma, Lymphoma, Human papilloma virus-associated cancers, and non-AIDS-Defining cancers. The Network Laboratories will be responsible for routine clinical trial support activities, pathogenesis-driven correlative studies, and clinical pharmacology and pharmacokinetics studies of anticancer/antiviral interactions. All clinical trials to be conducted by the AMC must be available to subjects of all racial/ethnic groups. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-056.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00254782 | Dec 10, 2019 | Jan 10, 2020 | View |
Package 1
Mandatory forms
320521 RR_SF424_2_0-2.0.pdf
320521 PHS398_CoverPageSupplement_4_0-4.0.pdf
320521 RR_OtherProjectInfo_1_4-1.4.pdf
320521 PerformanceSite_2_0-2.0.pdf
320521 RR_KeyPersonExpanded_2_0-2.0.pdf
320521 RR_Budget_1_4-1.4.pdf
320521 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
320521 RR_SubawardBudget30_1_4-1.4.pdf
320521 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
